Chlamydia pneumoniae - Specific humoral immune responses and clinical disease parameters in multiple sclerosis [1]

Annals of Neurology

Volumn 49, Issue 1, 2001, Pages 135-

  Krametter, D ^a   Niederwieser, G ^a   Berghold, A ^a   Birnbaum, G ^a   Strasser Fuchs, S ^a   Hartung, H P ^a   Archelos, J J ^a,b  

^a KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^b Minneapolis Clinic of Neurology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; CHLAMYDOPHILA PNEUMONIAE; DISABILITY; DISEASE ACTIVITY; DISEASE DURATION; GENDER; HUMAN; HUMORAL IMMUNITY; LETTER; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; MULTIPLE SCLEROSIS;

EID: 0035109470     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200101)49:1<135::AID-ANA23>3.0.CO;2-T     Document Type: Letter

References (6)

1. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis
2. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
3. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS
4. The European Union Concerted Action on Virus Meningitis and Encephalitis. The detection of intrathecal synthesis of anti-herpes simplex IgG antibodies: Comparison between an antigen-mediated immunoblotting technique and antibody index calculations
5. Chlamydia pneumoniae (TWAR)
6. The virology of demyelinating diseases